1. Forte, J.S. (2006) Contrast Media: Chemistry, Pharmacology and Pharmaceutical Aspects. Course of Study for the Certificate of Competence in Administering Intravenous Injection.
2. Sigman, E.M., Elwood, C., Reagan, M.E., Morris, A.M. and Catanzaro, A. (1965) The renal clearance of I-131 labeled sodium iothalamate in man. Invest Urol, 2, 432–8.
3. Agarwal, R., Bills, J.E., Yigazu, P.M., Abraham, T., Gizaw, A.B., Light, R.P., Bekele, D.M. and Tegegne, G.G. (2009) Assessment of iothalamate plasma clearance: Duration of study affects quality of GFR. Clin J Am Soc Nephrol, 4, 77–85.
4. Lewis, J., Greene, T., Appel, L., Contreras, G., Douglas, J., Lash, J., Toto, R., Van Lente, F., Wang, X. and Wright, J.T., Jr. (2004) A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol, 15, 3175–83.
5. Agarwal, R. (2003) Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease. Am J Kidney Dis, 41, 752–9.